These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 21122575)

  • 1. Serum prohepcidin levels in chronic inflammatory bowel diseases.
    Nagy J; Lakner L; Poór VS; Pandur E; Mózsik G; Miseta A; Sipos K
    J Crohns Colitis; 2010 Dec; 4(6):649-53. PubMed ID: 21122575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum hepcidin concentrations correlate with ferritin in patients with inflammatory bowel disease.
    Mecklenburg I; Reznik D; Fasler-Kan E; Drewe J; Beglinger C; Hruz P;
    J Crohns Colitis; 2014 Nov; 8(11):1392-7. PubMed ID: 24825446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum hepcidin and prohepcidin concentrations in inflammatory bowel disease.
    Oustamanolakis P; Koutroubakis IE; Messaritakis I; Malliaraki N; Sfiridaki A; Kouroumalis EA
    Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):262-8. PubMed ID: 21285884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepcidin and inflammatory bowel disease: dual role in host defence and iron homoeostasis.
    Arnold J; Sangwaiya A; Bhatkal B; Geoghegan F; Busbridge M
    Eur J Gastroenterol Hepatol; 2009 Apr; 21(4):425-9. PubMed ID: 19262400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of serum procalcitonin in determining the activity of inflammatory bowel disease.
    Oruç N; Ozütemiz O; Osmanoğlu N; Ilter T
    Turk J Gastroenterol; 2009 Mar; 20(1):9-12. PubMed ID: 19330729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum prohepcidin concentrations in rheumatoid arthritis.
    Jayaranee S; Sthaneshwar P; Sokkalingam S
    Pathology; 2009 Feb; 41(2):178-82. PubMed ID: 18972320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-TNF-Mediated Modulation of Prohepcidin Improves Iron Availability in Inflammatory Bowel Disease, in an IL-6-Mediated Fashion.
    Cavallaro F; Duca L; Pisani LF; Rigolini R; Spina L; Tontini GE; Munizio N; Costa E; Cappellini MD; Vecchi M; Pastorelli L
    Can J Gastroenterol Hepatol; 2017; 2017():6843976. PubMed ID: 28191453
    [No Abstract]   [Full Text] [Related]  

  • 8. Prohepcidin and iron metabolism parameters in the obese elderly patients with anemia.
    Przybyszewska J; Zekanowska E; Kedziora-Kornatowska K; Boinska J; Cichon R; Porzych K
    J Nutr Health Aging; 2011 Apr; 15(4):259-64. PubMed ID: 21437556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does hepcidin affect erythropoiesis in hemodialysis patients?
    Eleftheriadis T; Kartsios C; Liakopoulos V; Antoniadi G; Ditsa M; Papadopoulos C; Anifandis G; Skirta A; Markala D; Stefanidis I
    Acta Haematol; 2006; 116(4):238-44. PubMed ID: 17119323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How does short-term low-dose simvastatin influence serum prohepcidin levels in patients with end-stage renal disease? A pilot study.
    Li XY; Chang JP; Su ZW; Li JH; Peng BS; Zhu SL; Cai AJ; Zhang J; Jiang Y
    Ther Apher Dial; 2010 Jun; 14(3):308-14. PubMed ID: 20609184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of prohepcidin levels and iron parameters on early post-transplantation toxicities.
    Akı SZ; Paşaoğlu H; Yeğin ZA; Suyanı E; Demirtaş CY; Ozkurt ZN; Yağcı M; Sucak GT
    Hematology; 2011 Sep; 16(5):284-90. PubMed ID: 21902892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosing anemia in inflammatory bowel disease: beyond the established markers.
    Oustamanolakis P; Koutroubakis IE; Kouroumalis EA
    J Crohns Colitis; 2011 Oct; 5(5):381-91. PubMed ID: 21939910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum hepcidin in inflammatory bowel diseases: biological and clinical significance.
    Bergamaschi G; Di Sabatino A; Albertini R; Costanzo F; Guerci M; Masotti M; Pasini A; Massari A; Campostrini N; Corbella M; Girelli D; Corazza GR
    Inflamm Bowel Dis; 2013 Sep; 19(10):2166-72. PubMed ID: 23867871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of serum prohepcidin, iron status and zinc-protoporphyrin in a random group of patients with malignant diseases.
    Grudeva-Popova JG; Terzieva DD; Nenova IS
    J BUON; 2011; 16(2):361-5. PubMed ID: 21766512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of Prohepcidin levels with anemia and inflammatory markers in non-diabetic uremic patients: a controlled study.
    Aydin Z; Gursu M; Karadag S; Uzun S; Sumnu A; Doventas Y; Ozturk S; Kazancioglu R
    Ren Fail; 2014 Sep; 36(8):1253-7. PubMed ID: 25040737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproducibility of and correspondence among different hepcidin forms in blood and urine and their relationships to iron status in healthy, male Guatemalan volunteers observed over 9 weeks.
    Schuemann K; Solomons NW; Laarakkers CM; Romero-Abal ME; Kroll S; Weiss G; Swinkels DW
    Ann Nutr Metab; 2011; 58(2):158-66. PubMed ID: 21654163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum prohepcidin levels in chronic hepatitis C, alcoholic liver disease, and nonalcoholic fatty liver disease.
    Lee SH; Jeong SH; Park YS; Hwang JH; Kim JW; Kim N; Lee DH
    Korean J Hepatol; 2010 Sep; 16(3):288-94. PubMed ID: 20924211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low serum levels of prohepcidin, but not hepcidin-25, are related to anemia in familial amyloidosis TTR V30M.
    Beirão I; Almeida S; Swinkels D; Costa PM; Moreira L; Fonseca I; Freitas C; Cabrita A; Porto G
    Blood Cells Mol Dis; 2008; 41(2):175-8. PubMed ID: 18544472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between thrombocytosis and iron deficiency anemia in inflammatory bowel disease.
    Voudoukis E; Karmiris K; Oustamanolakis P; Theodoropoulou A; Sfiridaki A; Paspatis GA; Koutroubakis IE
    Eur J Gastroenterol Hepatol; 2013 Oct; 25(10):1212-6. PubMed ID: 23839158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.